Senior Principal Scientist
Bristol Myers Squibb
Redwood City, California
Srikanth obtained his PhD in Medicinal and Pharmaceutical Chemistry from University of Minnesota, Twin Cities in 2013. Srikanth Joined BMS, Redwood City, CA in 2014 and currently leads the bioanalytical team to support the early discovery efforts of oncology and immuno-oncology portfolio. His team is focused on development of bioanalytical methods by LBA and LC-MS for PK and biotransformation assessment of various therapeutic modalities including small molecule, antibodies, ADCs, bispecifics and fusion proteins.
Disclosure information not submitted.
Monday, October 17, 2022
9:00 AM – 9:30 AM ET